CK Kasper

727 total citations
21 papers, 585 citations indexed

About

CK Kasper is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, CK Kasper has authored 21 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Genetics and 4 papers in Genetics. Recurrent topics in CK Kasper's work include Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). CK Kasper is often cited by papers focused on Hemophilia Treatment and Research (14 papers), Platelet Disorders and Treatments (8 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). CK Kasper collaborates with scholars based in United States, Netherlands and Spain. CK Kasper's co-authors include SI Rapaport, Uri Seligsohn, Bjarne Østerud, DI Feinstein, PH Reitsma, R M Bertina, E Briët, E.M. Essien, Graham Jb and PM Mannucci and has published in prestigious journals such as Blood and UNC Libraries.

In The Last Decade

CK Kasper

19 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
CK Kasper United States	12	487	127	94	70	60	21	585
W. Sommerfeld Germany	6	217 0.4×	168 1.3×	98 1.0×	21 0.3×	20 0.3×	8	410
DE Stepan United States	7	314 0.6×	93 0.7×	63 0.7×	39 0.6×	14 0.2×	9	503
Bruno Basolo Italy	13	121 0.2×	40 0.3×	106 1.1×	162 2.3×	73 1.2×	39	575
M. J. M. L. Gilmore United Kingdom	7	452 0.9×	135 1.1×	51 0.5×	34 0.5×	6 0.1×	10	548
E. P. Alessandrino Italy	11	345 0.7×	110 0.9×	115 1.2×	30 0.4×	13 0.2×	26	505
Fanny Tabarin France	5	191 0.4×	79 0.6×	101 1.1×	51 0.7×	184 3.1×	7	540
Shulman Hm United States	7	184 0.4×	37 0.3×	29 0.3×	33 0.5×	12 0.2×	7	376
ME Nesbit United States	8	429 0.9×	91 0.7×	50 0.5×	34 0.5×	7 0.1×	12	490
A. E. G. Kr. v. d. Borne Netherlands	13	215 0.4×	99 0.8×	82 0.9×	254 3.6×	98 1.6×	17	603
Horia Bumbea Romania	12	229 0.5×	144 1.1×	79 0.8×	29 0.4×	27 0.5×	70	462

Countries citing papers authored by CK Kasper

Since Specialization

Citations

This map shows the geographic impact of CK Kasper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CK Kasper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CK Kasper more than expected).

Fields of papers citing papers by CK Kasper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CK Kasper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CK Kasper. The network helps show where CK Kasper may publish in the future.

Co-authorship network of co-authors of CK Kasper

This figure shows the co-authorship network connecting the top 25 collaborators of CK Kasper. A scholar is included among the top collaborators of CK Kasper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CK Kasper. CK Kasper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Stafford, Darrel W., et al.. (2021). Factor IX San Dimas. Substitution of glutamine for Arg-4 in the propeptide leads to incomplete gamma-carboxylation and altered phospholipid binding properties.. UNC Libraries.

2.

Kuppuswamy, M, et al.. (1990). Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain. Blood. 76(8). 1530–1537. 17 indexed citations

3.

Kuppuswamy, M, et al.. (1990). Factor IXHollywood: substitution of Pro55 by Ala in the first epidermal growth factor-like domain. Blood. 76(8). 1530–1537. 1 indexed citations

4.

Reitsma, PH, et al.. (1989). Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood. 73(3). 743–746. 2 indexed citations

5.

Reitsma, PH, et al.. (1989). Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). Blood. 73(3). 743–746. 40 indexed citations

6.

Mannucci, PM, et al.. (1986). Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminant. Blood. 67(6). 1560–1567. 28 indexed citations

7.

Batlle, Javier, Manuel Campos, B. Justiça, et al.. (1986). The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood. 68(6). 1207–1212. 52 indexed citations

8.

Kasper, CK, et al.. (1986). Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood. 68(2). 472–478. 2 indexed citations

9.

Jb, Graham, et al.. (1986). Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype. Blood. 67(6). 1554–1559. 35 indexed citations

10.

Kasper, CK, et al.. (1986). The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood. 68(6). 1207–1212. 5 indexed citations

11.

Kasper, CK, et al.. (1986). Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood. 68(2). 472–478. 63 indexed citations

12.

Kasper, CK, et al.. (1985). Distinctive lymphocyte subpopulation abnormalities in patients with congenital coagulation disorders who exhibit lymph node enlargement. Blood. 66(1). 64–68. 12 indexed citations

13.

Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 30 indexed citations

14.

Eyster, M. Elaine, PM Catalano, CW McMillan, et al.. (1985). Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood. 66(6). 1317–1320. 23 indexed citations

15.

Kasper, CK, et al.. (1979). Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood. 53(5). 828–837. 9 indexed citations

16.

Seligsohn, Uri, CK Kasper, Bjarne Østerud, & SI Rapaport. (1979). Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood. 53(5). 828–837. 120 indexed citations

17.

Kasper, CK, et al.. (1977). Hemophilia B: characterization of genetic variants and detection of carriers. Blood. 50(3). 351–366. 69 indexed citations

18.

Kasper, CK, et al.. (1977). Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 49(5). 793–797. 60 indexed citations

19.

Kasper, CK, et al.. (1977). Hemophilia B: characterization of genetic variants and detection of carriers. Blood. 50(3). 351–366. 3 indexed citations

20.

Kasper, CK, et al.. (1977). Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 49(5). 793–797. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact